X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases

作者: Zhenzhen Jia , Zhengtong Pei , Yuanyuan Li , Liumei Wei , Kirby D. Smith

DOI: 10.1016/J.YMGME.2004.06.015

关键词: EndocrinologyWestern blotAdrenal glandMessenger RNAPeroxisomeBiologyBiochemistryEnzymeFatty acid metabolismAdrenoleukodystrophyInternal medicineMetabolism

摘要: The principal biochemical abnormality in the neurodegenerative disorder X-linked adrenoleukodystrophy (X-ALD) is elevated plasma and tissue levels of very long-chain fatty acids (VLCFA). Enzymes with acyl-CoA synthetase (VLACS) activity are required for VLCFA metabolism, including degradation by peroxisomal β-oxidation or incorporation into complex lipids, may also participate synthesis. Two enzymes VLACS activity, ACSVL1 BG1, were investigated their potential role X-ALD pathology. Skin fibroblast mRNA ACSVL1, an enzyme previously shown to be peroxisomes β-oxidation, not significantly different between normal controls, patients childhood cerebral X-ALD, adrenomyeloneuropathy. Similar results obtained a non-peroxisomal that highly expressed nervous system, adrenal gland, testis, tissues pathologically affected X-ALD. No significant differences immunohistochemical staining patterns expressing either BG1 observed when wild-type mice compared. Western blot analysis protein showed no fibroblasts from adrenomyeloneuropathy patients. similar mouse brain, spinal cord, gland. We hypothesized one function was direct cholesterol ester synthesis pathway. However, depletion Neuro2a cells using RNA interference did decrease labeled esters. conclude role, if any, pathology indirect.

参考文章(43)
L. T. Braiterman, A. B. Moser, F. Kok, H. W. Moser, K. D. Smith, P. A. Watkins, He-Ming Wei, M. A. Smith, S. J. Gould, Altered expression of ALDP in X-linked adrenoleukodystrophy. American Journal of Human Genetics. ,vol. 57, pp. 292- 301 ,(1995)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Shoji TSUJI, Tsukasa OHNO, Tadashi MIYATAKE, Akemi SUZUKI, Tamio YAMAKAWA, Fatty Acid Elongation Activity in Fibroblasts from Patients with Adrenoleukodystrophy (ALD) Journal of Biochemistry. ,vol. 96, pp. 1241- 1247 ,(1984) , 10.1093/OXFORDJOURNALS.JBCHEM.A134942
J.-F. Lu, A. M. Lawler, P. A. Watkins, J. M. Powers, A. B. Moser, H. W. Moser, K. D. Smith, A mouse model for X-linked adrenoleukodystrophy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 9366- 9371 ,(1997) , 10.1073/PNAS.94.17.9366
Barbara A. Fitscher, Hans-Dieter Riedel, Kirstin C. Young, Wolfgang Stremmel, Tissue distribution and cDNA cloning of a human fatty acid transport protein (hsFATP4) Biochimica et Biophysica Acta. ,vol. 1443, pp. 381- 385 ,(1998) , 10.1016/S0167-4781(98)00231-0
Steven J. Steinberg, Stephan Kemp, Lelita T. Braiterman, Paul A. Watkins, Role of very-long-chain acyl-coenzyme A synthetase in X-linked adrenoleukodystrophy. Annals of Neurology. ,vol. 46, pp. 409- 412 ,(1999) , 10.1002/1531-8249(199909)46:3<409::AID-ANA18>3.0.CO;2-9
Steven J. Steinberg, Susan J. Wang, Do G. Kim, Stephanie J. Mihalik, Paul A. Watkins, Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochemical and Biophysical Research Communications. ,vol. 257, pp. 615- 621 ,(1999) , 10.1006/BBRC.1999.0510
R.J.A. Wanders, C.W.T. van Roermund, M.J.A. van Wijland, R.B.H. Schutgens, H. van den Bosch, A.W. Schram, J.M. Tager, Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids Biochemical and Biophysical Research Communications. ,vol. 153, pp. 618- 624 ,(1988) , 10.1016/S0006-291X(88)81140-9
Paul A. Watkins, FATTY ACID ACTIVATION Progress in Lipid Research. ,vol. 36, pp. 55- 83 ,(1997) , 10.1016/S0163-7827(97)00004-0